Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $618.1M
- Net income
- -$860.2M
- Net margin
- -139.2%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $760.5M
- Cash
- $330.7M
Comfortably covers what is due within a year.
- Current assets
- $636.3M
- Current liabilities
- $222.8M
- Current ratio
- 2.86
Consumes cash and must keep raising it.
- Operating cash flow
- -$456.0M
- Free cash flow
- -$458.2M
- FCF margin
- -74.1%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 63.4M
- Share growth (1y)
- 27.4%
- Cash runway
- 9 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MIRM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 176.24 M | 159.88 M | 148.93 M | 133.01 M | 127.78 M | 111.58 M |
| Revenue Growth (YoY) | 37.92 % | 43.28 % | 49.81 % | 47.17 % | 64.09 % | 61.20 % |
| Cost of Revenue | 30.35 M | 28.88 M | 28.34 M | 25.54 M | 23.42 M | 23.02 M |
| Gross Profit | 145.90 M | 131.00 M | 120.59 M | 107.47 M | 104.36 M | 88.57 M |
| SG&A Expense | 81.47 M | 96.33 M | 74.13 M | 61.91 M | 63.29 M | 57.71 M |
| R&D Expense | 90.53 M | 97.91 M | 51.11 M | 42.96 M | 46.07 M | 46.04 M |
| Operating Expenses | 188.43 M | 194.24 M | 125.23 M | 104.87 M | 109.35 M | 103.75 M |
| Operating Income | -42.54 M | -63.16 M | -4.57 M | 2.60 M | -4.99 M | -15.18 M |
| Pretax Income | -65.54 M | -789.68 M | -4.96 M | 2.64 M | -5.46 M | -13.65 M |
| Tax Provision | 1.69 M | 475.00 K | 767.00 K | -262.00 K | 402.00 K | 1.03 M |
| Net Income | -67.23 M | -790.15 M | -5.73 M | 2.90 M | -5.86 M | -14.68 M |
| EPS (Basic) | -1.06 | -13.43 | -0.12 | 0.05 | -0.12 | -0.30 |
| EPS (Diluted) | -1.06 | -13.43 | -0.12 | 0.05 | -0.12 | -0.30 |
| Shares Outstanding | 63.37 M | 58.85 M | 50.20 M | 56.99 M | 49.73 M | 48.89 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.